Literature DB >> 10391873

Heterophile antibodies to bovine and caprine proteins causing false-positive human immunodeficiency virus type 1 and other enzyme-linked immunosorbent assay results.

J H Willman1, T B Martins, T D Jaskowski, H R Hill, C M Litwin.   

Abstract

Heterophile antibodies are a well-recognized cause of erroneous results in immunoassays. We describe here a 22-month-old child with heterophile antibodies reactive with bovine serum albumin and caprine proteins causing false-positive results to human immunodeficiency virus type 1 and other infectious serology testing.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10391873      PMCID： PMC95738          DOI： 10.1128/CDLI.6.4.615-616.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  7 in total

Review 1.  Antibody multispecificity in immunoassay interference.

Authors:  S S Levinson
Journal:  Clin Biochem       Date:  1992-04       Impact factor: 3.281

2.  Interference by human anti-mouse antibody in two-site immunoassays.

Authors:  L J Kricka; D Schmerfeld-Pruss; M Senior; D B Goodman; P Kaladas
Journal:  Clin Chem       Date:  1990-06       Impact factor: 8.327

3.  Heteroantibody: phantom of the immunoassay.

Authors:  M H Nahm; J W Hoffmann
Journal:  Clin Chem       Date:  1990-06       Impact factor: 8.327

4.  Anti-murine antibody response to mouse monoclonal antibodies: clinical findings and implications.

Authors:  J C Reynolds; S Del Vecchio; H Sakahara; M E Lora; J A Carrasquillo; R D Neumann; S M Larson
Journal:  Int J Rad Appl Instrum B       Date:  1989

5.  Heterophilic antibodies produce spuriously elevated concentrations of the MB isoenzyme of creatine kinase in a selected patient population.

Authors:  R C Sosolik; C L Hitchcock; W J Becker
Journal:  Am J Clin Pathol       Date:  1997-05       Impact factor: 2.493

6.  Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

Authors:  R W Schroff; K A Foon; S M Beatty; R K Oldham; A C Morgan
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

7.  Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes.

Authors:  M A Atkinson; M A Bowman; K J Kao; L Campbell; P J Dush; S C Shah; O Simell; N K Maclaren
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245
  7 in total
  6 in total

1.  Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum.

Authors:  Thomas B Martins; Brian M Pasi; Christine M Litwin; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Authors:  Eric Kuhn; Jeffrey R Whiteaker; D R Mani; Angela M Jackson; Lei Zhao; Matthew E Pope; Derek Smith; Keith D Rivera; N Leigh Anderson; Steven J Skates; Terry W Pearson; Amanda G Paulovich; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

3.  Elimination of false-positive results in a luminex assay for pneumococcal antibodies.

Authors:  Jerry W Pickering; Matthew T Larson; Thomas B Martins; Susan S Copple; Harry R Hill
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

Review 4.  The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry.

Authors:  Andrew N Hoofnagle; Mark H Wener
Journal:  J Immunol Methods       Date:  2009-06-16       Impact factor: 2.303

5.  False-positive human immunodeficiency virus antibody test in a dialysis patient.

Authors:  Douglas M Silverstein; Diego H Aviles; V Matti Vehaskari
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

6.  A retrospective analysis of false-positive infectious screening results in blood donors.

Authors:  Michelle T Vo; Roberta Bruhn; Zhanna Kaidarova; Brian S Custer; Edward L Murphy; Evan M Bloch
Journal:  Transfusion       Date:  2015-10-28       Impact factor: 3.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.